QUINTO, ILEANA
 Distribuzione geografica
Continente #
NA - Nord America 4.184
AS - Asia 2.283
EU - Europa 1.112
SA - Sud America 398
Continente sconosciuto - Info sul continente non disponibili 128
AF - Africa 36
OC - Oceania 3
Totale 8.144
Nazione #
US - Stati Uniti d'America 4.038
SG - Singapore 1.104
CN - Cina 559
IT - Italia 526
BR - Brasile 315
VN - Vietnam 214
IN - India 184
DE - Germania 147
SE - Svezia 136
GB - Regno Unito 109
CA - Canada 104
FI - Finlandia 55
KR - Corea 47
HK - Hong Kong 45
MX - Messico 27
FR - Francia 26
AR - Argentina 25
BD - Bangladesh 25
NL - Olanda 20
JP - Giappone 19
EC - Ecuador 17
ZA - Sudafrica 17
ID - Indonesia 16
UA - Ucraina 16
ES - Italia 11
RU - Federazione Russa 10
PE - Perù 9
IQ - Iraq 8
PL - Polonia 8
VE - Venezuela 8
CL - Cile 7
CO - Colombia 7
CZ - Repubblica Ceca 7
IL - Israele 7
AT - Austria 6
RO - Romania 6
SA - Arabia Saudita 6
PK - Pakistan 5
PY - Paraguay 5
TR - Turchia 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
GR - Grecia 4
IR - Iran 4
JM - Giamaica 4
KE - Kenya 4
KZ - Kazakistan 4
LT - Lituania 4
MA - Marocco 4
MY - Malesia 4
NP - Nepal 4
PT - Portogallo 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
DZ - Algeria 3
EU - Europa 3
IE - Irlanda 3
TH - Thailandia 3
TN - Tunisia 3
UZ - Uzbekistan 3
BB - Barbados 2
EE - Estonia 2
KG - Kirghizistan 2
MD - Moldavia 2
MN - Mongolia 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PH - Filippine 2
SY - Repubblica araba siriana 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
JO - Giordania 1
KW - Kuwait 1
MM - Myanmar 1
NG - Nigeria 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SR - Suriname 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 8.022
Città #
San Jose 716
Dallas 421
Chandler 394
Singapore 391
Ashburn 327
Santa Clara 188
Bengaluru 140
Hefei 140
Milan 139
Princeton 136
Lawrence 134
Council Bluffs 118
Munich 114
Beijing 99
Catanzaro 80
Ho Chi Minh City 80
Wilmington 76
London 69
Ottawa 67
Chicago 51
Turku 49
Des Moines 45
Hong Kong 44
Hanoi 43
Boardman 41
Seattle 39
Los Angeles 38
São Paulo 26
Shanghai 25
New York 24
Phoenix 22
Naples 21
Napoli 20
Guangzhou 18
Brooklyn 17
Montreal 15
Rome 15
Taranto 15
San Francisco 14
Augusta 13
Columbus 13
Gwangjin-gu 13
Redmond 13
The Dalles 13
Seoul 11
Shenzhen 11
Tokyo 11
Boston 10
Haiphong 10
Johannesburg 10
Marano 9
Norwalk 9
Rio de Janeiro 9
Buffalo 8
Mexico City 8
Paris 8
Stockholm 8
Warsaw 8
Amsterdam 7
Da Nang 7
Foggia 7
Houston 7
Olomouc 7
Orem 7
Pune 7
Thái Bình 7
Xi'an 7
Denver 6
Gangbuk-gu 6
Hanover 6
Helsinki 6
Mumbai 6
Redwood City 6
Atlanta 5
Guayaquil 5
Hadfield 5
Jiaxing 5
Manchester 5
Toronto 5
Vienna 5
Athens 4
Aversa 4
Buenos Aires 4
Campinas 4
Caserta 4
Cleveland 4
Dongyang 4
Edmonton 4
Florence 4
Fortaleza 4
Guarulhos 4
Las Vegas 4
Latina 4
Lima 4
Madrid 4
Marseille 4
Padova 4
Philadelphia 4
Quito 4
Reggio Calabria 4
Totale 4.820
Nome #
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 154
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 106
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtkγ. 101
Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α 100
A novel phage display based platform for exosome diversity characterization 99
Comparative toxicity of diphenyl, diphenyl ether and some of their hydroxyderivatives 98
Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43 96
Phage display-derived peptides as tool for single B cell populations targeting in polyclonal CLL patients 96
B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy 93
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtk-gamma 91
Evidence for a novel Cullin-3/IBtk human ubiquitin ligase complex 91
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappaB 87
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 86
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis 86
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. 85
Crucial role for IBtk in the survival and maintenance of mature B cells 85
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 85
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors 84
In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder 81
Human immunodeficiency virus-1 Tat activates NF-kappaB via physical interaction with IkappaB-alpha and p65 79
Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet 79
Cancer-associated CD43 glycoforms as target of immunotherapy 79
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 78
IkappaB-alpha Represses the Transcriptional Activity of the HIV-1 Tat Transactivator by Promoting Its Nuclear Export 78
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 78
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 77
Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein 76
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 76
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy 76
FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma 75
Cancer-associated CD43 glycoforms as target of immunotherapy 75
Computational analysis and in vivo validation of a microRNA encoded by the IBTK gene, a regulator of B-lymphocytes differentiation and survival 74
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 72
Inhibition of HIV-1 replication in primary human monocytes by the IkappaB-alfaS32/36A repressor of NF-kappaB 72
Abstract 1814: Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 72
Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein 71
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 70
The aftermath of the Merck's HIV vaccine trial 68
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 67
Autocrine growth function of interleukin-1 and interleukin-6 molecules on human transformed B cells 66
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 65
The expression of Inhibitor of Bruton’s Tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukemia conferring resistance to apoptosis 64
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 64
IBtkα Activates the β‐Catenin‐Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3βin Cancerous B Cells 64
A comparative study on the toxicity and mutagenicity of biphenyl (BP) and diphenyl ether (DPE) in sea urchin, S. typhimurium and S. cerevisiae. 63
Spontaneous and mutagen-mediated amplification of a neo gene integrated at different genomic sites in Rat 2 fibroblasts 63
A NF-kB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kB-activating stimuli 63
DNA damaging agents increase the stability of interleukin-1alfa, interleukin-1beta and interleukin-6 transcripts and the production of the relative proteins 63
Id-peptides as new tools for diagnosis and treatment of B-cell Chronic Lymphocytic Leukemia (B-CLL) 63
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay 62
High attenuation and immunogenicity of a simian immunodeficiency virus expressing a proteolysis-resistant inhibitor of NF-kappa B 62
Molecular characterization of tumor-derived exosomes as tool for minimal residual disease monitoring 62
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E- myc Mice 62
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival 62
Carcinogenic potency in rodents versus genotoxic potency in E. coli: a correlation analysis for bifunctional alkylating agents 61
Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 61
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 61
Phage Display: An Overview in Context to Drug Discovery 61
The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis 61
Mutagenicity of twelve imidazole derivatives with trichomonacide activity 60
I tests di mutagenesi nella valutazione della tossicologia dei farmaci. 60
Crucial role for IBtkgamma in the survival and maintenance of matureB cells 60
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 59
High efficiency of site-directed mutagenesis mediated by a single PCR product 59
Phage Display: An Overview in Context to Drug Discovery 59
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 58
Partial purification and MALDI-TOF MS analysis of UN1, a tumor antigen membrane glycoprotein 58
Effect of DNOC, Ferbam and Imidan exposure on mouse sperm morphology 57
Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors 57
Id-peptides as biomarkers of B-cell Chronic Lymphocytic Leukemia 57
Epstein-Barr Virus Nuclear Antigen 2 transactivates the Long Terminal Repeat of Human Immunodeficiency Virus Type 1 55
Insights into Thymus Development and Viral Thymic Infections 55
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 55
Regulation of the HIV Promoter/Enhancer 54
Physical and functional interaction of HIV-1 Tat with E2F-4, a transcriptional regulator of mammalian cell cycle 54
Aspetti generali di tossicologia genetica 53
Exosome-associated miRNAs profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 53
Ultraviolet Mutagenesis 53
Expression of an exogenous interleukin-6 gene in human EBV-B cells confers growth advantage and in vivo tumorigenicity 52
Multimodal Imaging for a Theranostic Approach in a Murine Model of B-cell Lymphoma with Engineered Nanoparticles 51
Insights about myc and apoptosis in b-lymphomagenesis: An update from murine models 51
Screening of 24 pesticides by Salmonella/microsome assay: mutagenicity of benazolin, metoxuron and paraoxon. 50
Genotoxicity and teratogenicity of diphenyl and diphenyl ether: a study of sea urchins, yeast, and Salmonella typhimurium 50
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 50
Id peptide-based methodology to explore the antigenic diversity of B-cell Chronic Lymphocytic Leukemia (B-CLL) 50
Structural and functional insights into IκB-α/HIV-1 Tat interaction. 49
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring 49
Mutagenic epoxide impurities discovered in two beta-adrenergic blocking agents 48
Metodo di attenuazione stabile di retrovirus HIV-1 e SIV per acquisizione di funzione: sviluppo di un virus vaccino attenuato per l'AIDS 48
Molecular modeling of epitopes recognized by neoplastic B-cells in Chronic Lymphocytic Leukemia 48
Peptide-guided targeting of GPR55 for anti-cancer therapy. 48
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells 47
Impaired generation of bone marrow B-lymphocytes in mice deficient in C/EBP beta 47
Frameshift mutagenicity of furocoumarins in the dark 47
Further validation of the E. coli multitest: in vitro and in vivo metabolic activation of procarcinogens 46
Frameshift mutagenesis in the dark of furocoumarins proposed for photochemotherapy 45
Sperm abnormalities in mice exposed to diesel particulate 45
MUTAGENS ENHANCE THE HIV-1, INTERLEUKIN-1 (IL-1), AND INTERLEUKIN-6 (IL-6) EXPRESSION THROUGH TRANSCRIPTIONAL OR POSTTRANSCRIPTIONAL MECHANISMS 44
Perspectives for a Protective HIV-1 Vaccine in "HIV-1: Molecular Biology and Pathogenesis" 44
Induction of tumorigenicity and plasmacytoid differentiation in EBV-B cells by expression of exogenous interleukin-6 or IL-6 receptor genes. 44
Totale 6.678
Categoria #
all - tutte 75.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.607


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022446 0 0 7 111 27 10 21 130 29 50 58 3
2022/20231.175 270 35 62 67 126 95 7 114 227 68 80 24
2023/2024477 98 60 60 25 28 116 3 15 6 7 19 40
2024/20251.693 242 96 93 56 136 186 26 46 245 93 185 289
2025/20263.432 197 381 566 490 332 159 400 206 366 194 97 44
2026/2027520 29 144 347 0 0 0 0 0 0 0 0 0
Totale 8.144